Diabetes and Endocrinology

Two metformin products recalled, more on the way

June 02, 2020

Immediately after the FDA said it found elevated levels of the carcinogenic ingredient N-nitrosodimethylamine (NDMA) in certain extended release (ER) metformin products, the first 2 major recalls are underway.

Pharma exec: New type 2 diabetes treatment competitively priced

September 24, 2019

How the first oral GLP-1 oral treatment for type 2 diabetes is unique and how it will be priced compared to other GLP-1 medications.

FDA clears first ready-to-use insulin for IV infusion

July 22, 2019

FDA approved the first and only ready-to-use insulin for IV infusion in hospitals and acute care settings.

FDA fast tracks blockbuster diabetes drug for heart failure

July 08, 2019

FDA granted Fast Track designation to a popular diabetes drug to reduce the risk of cardiovascular death and hospitalization for heart failure in people with chronic heart failure.

Lack of insulin competition high priority for FDA

April 02, 2019

FDA fast-tracks biosimiliar insulin products to elevate competition.

Eli Lilly launches generic insulin ahead of Congressional hearings

March 06, 2019

FDA clears novel diabetes, tropical disease therapies

February 19, 2019

FDA approved first interoperable insulin pump, as well as the only FDA-approved drug for patients with a neglected tropical disease.

FDA approves first long-term implantable glucose-monitoring system

June 25, 2018

Overtreating glucose levels can take a toll on diabetes patients

July 29, 2016

Mayo Clinic researchers found that beyond overtesting, focus on HbA1C levels can lead to serious harms for patients, especially as more diabetes drugs are needed to keep HbA1C within desired targets.

Wide geographic differences exist in treating diabetes

July 29, 2016

A large-scale observational study led by Columbia University researchers may offer new approach to studying diverse patient groups.